Literature DB >> 23954130

Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

Ju Qiu1, Xiaohuan Guo, Zong-Ming E Chen, Lei He, Gregory F Sonnenberg, David Artis, Yang-Xin Fu, Liang Zhou.   

Abstract

Aryl hydrocarbon receptor (Ahr) is crucial for the maintenance and function of group 3 innate lymphoid cells (ILCs), which are important in gut immunity. Because Ahr promotes T helper 17 (Th17) cell differentiation in vitro, it is reasonable to expect that Ahr would enhance Th17 cells in vivo. Instead, we show that Ahr deficiency caused increased intestinal Th17 cells, raising the possibility that group 3 ILCs could negatively regulate Th17 cells. Reduced innate interleukin-22 (IL-22) in Ahr-deficient mice allowed expansion of commensal segmented filamentous bacteria (SFB), known to promote Th17 cells. Compared to Rorc(+/+)Ahr(-/-) mice, Rorc(gfp/+)Ahr(-/-) mice had further reduced group 3 ILCs and were prone to spontaneous colitis with increased SFB and Th17 cells. Innate expression of Ahr played a protective role in T-cell-mediated experimental colitis by suppressing pathogenic Th17 cells. Our data reveal an intricate balance between ILCs and Th17 cells regulated by Ahr and commensal flora.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954130      PMCID: PMC3884586          DOI: 10.1016/j.immuni.2013.08.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  70 in total

1.  Lineage relationship analysis of RORgammat+ innate lymphoid cells.

Authors:  Shinichiro Sawa; Marie Cherrier; Matthias Lochner; Naoko Satoh-Takayama; Hans Jörg Fehling; Francina Langa; James P Di Santo; Gérard Eberl
Journal:  Science       Date:  2010-09-23       Impact factor: 47.728

2.  Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells.

Authors:  Ana Reynders; Nadia Yessaad; Thien-Phong Vu Manh; Marc Dalod; Aurore Fenis; Camille Aubry; Georgios Nikitas; Bertrand Escalière; Jean Christophe Renauld; Olivier Dussurget; Pascale Cossart; Marc Lecuit; Eric Vivier; Elena Tomasello
Journal:  EMBO J       Date:  2011-06-17       Impact factor: 11.598

3.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

4.  Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.

Authors:  Yugang Wang; Ekaterina P Koroleva; Andrei A Kruglov; Dmitry V Kuprash; Sergei A Nedospasov; Yang-Xin Fu; Alexei V Tumanov
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

5.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells.

Authors:  Ju Qiu; Jennifer J Heller; Xiaohuan Guo; Zong-ming E Chen; Kamonwan Fish; Yang-Xin Fu; Liang Zhou
Journal:  Immunity       Date:  2011-12-15       Impact factor: 31.745

Review 6.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

7.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Authors:  Tetsuro Takayama; Nobuhiko Kamada; Hiroshi Chinen; Susumu Okamoto; Mina T Kitazume; Jonathan Chang; Yumi Matuzaki; Sadafumi Suzuki; Akira Sugita; Kazutaka Koganei; Tadakazu Hisamatsu; Takanori Kanai; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2010-06-01       Impact factor: 22.682

8.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

View more
  194 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

Review 2.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 3.  Microbiota and host immune responses: a love-hate relationship.

Authors:  Sarah Tomkovich; Christian Jobin
Journal:  Immunology       Date:  2015-11-02       Impact factor: 7.397

4.  Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Authors:  Shiyang Li; Jennifer J Heller; John W Bostick; Aileen Lee; Hilde Schjerven; Philippe Kastner; Susan Chan; Zongming E Chen; Liang Zhou
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 5.  Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.

Authors:  Jing Gong; Sanjeev Noel; Jennifer L Pluznick; Abdel Rahim A Hamad; Hamid Rabb
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

Review 6.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 7.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 8.  Recent trends and future directions for the medical treatment of ulcerative colitis.

Authors:  Makoto Naganuma; Shinta Mizuno; Kosaku Nanki; Shinya Sugimoto; Takanori Kanai
Journal:  Clin J Gastroenterol       Date:  2016-10-03

9.  Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.

Authors:  Satoru Kondo; Toshimitsu Araki; Yoshiki Okita; Akira Yamamoto; Yasuhiko Hamada; Masaki Katsurahara; Noriyuki Horiki; Misaki Nakamura; Takahiro Shimoyama; Takayuki Yamamoto; Yoshiyuki Takei; Masato Kusunoki
Journal:  Clin J Gastroenterol       Date:  2018-03-16

Review 10.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.